Vista Current Coverage

All posts by John Heerdink

It’s Time to Read The “Vista Partners Weekly Market Update 9-22-18?”…Stay Informed! Stay Competitive!

Vista Partners has published “Vista Partners Weekly Market Update 9-22-18!”  Each weekly issue is written by Vista Partners’ Managing Director, John Heerdink & includes updates on the stock market, a “Smallcap Stocks To Watch” section, & featured stories & videos from Vista’s Coverage Universe.  Vista Covers all Dow...

San Diego-based Fate Therapeutics Enters Strategic Collaboration with Tokyo’s ONO Pharmaceutical Co.

San Diego-based Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders. The Company is pioneering the development of off-the-shelf cell therapies using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company’s immuno-oncology...

Have You Read “Vista Partners Weekly Market Update 9-15-18?”

Vista Partners published “Vista Partners Weekly Market Update 9-15-18!”  Each weekly issue is written by Vista Partners’ Managing Director, John Heerdink! Each weekly issue includes updates on the stock market, a “Stocks To Watch” section, & featured daily stories & videos from Vista’s Coverage Universe of...

Will You Be One Of The First To Get Apple’s New iPhone Xs?

Dow 30 component Apple (AAPL) revolutionized personal technology with the introduction of the Macintosh in 1984. Today Apple leads the world in innovation with iPhone, iPad, Mac, Apple Watch and Apple TV. Apple’s four software platforms — iOS, macOS, watchOS, and tvOS — provide seamless...